Levamisole Hydrochloride first entered the global pharmaceutical scene back in the late 1960s, thanks to a French research team. At the time, the world needed better weapons against parasitic diseases. Scientists discovered its effectiveness after screening a library of compounds for anti-parasitic activity. Soon after approval, livestock farmers saw that it helped improve yields by clearing out intestinal worms in cattle, sheep, and swine. In the 1970s, clinicians extended its use to humans, treating worm infestations and even using it as an immunomodulator for rheumatoid arthritis and colon cancer. The compound's initial success is a reminder that scientific curiosity, government support, and collaboration can translate into practical tools for both agriculture and medicine.
Levamisole Hydrochloride does a number of jobs in the health and agricultural industries. In pure form, it takes shape as a white, odorless crystalline powder, and often lands on pharmaceutical market shelves in tablet or powder formulations. Veterinary products usually measure in granules, boluses, or injections. What stands out is its cost-effectiveness and wide therapeutic window. Manufacturers always pay close attention to batch purity since impurities can turn a valuable medication into something dangerous or useless, particularly with the scrutiny on animal and human health today.
Levamisole Hydrochloride’s molecular structure includes a thiazole ring and an imidazothiazole skeleton. Its molecular formula is C11H12N2S·HCl, with a molecular weight of about 240.75 g/mol. Solubility in water is high, which explains its popularity in injectable formulations and oral solutions. The compound melts at around 225°C, a detail that matters in processing and storage. It holds up well in closed containers but can break down in the presence of direct sunlight or high humidity. Stability under normal handling remains a strong point, which helps minimize waste and ensures accuracy in dosing, especially in low-resource areas.
Producers must stick to strict specifications for pharmaceutical and veterinary markets, which usually means 98–101% purity by HPLC testing and limited levels of any organic residues. Labels always indicate content weight, batch number, expiration date, and proper storage instructions—usually dry, cool, and out of direct light. Most jurisdictions require clear warnings about shelf-life and insist on tamper-evident packaging, which gives traceability and puts the user’s safety at the center. Differences in labeling requirements between regions force exporters and pharmaceutical companies to pay close attention to regulatory updates, especially for cross-border sales and clinical supply chains.
One widely used synthesis route starts from 2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b]thiazole as a precursor, which undergoes selective oxidation and hydrochloride salt formation. Industrial-scale manufacturing uses batch reactors operating under controlled temperature and pH, supported by purification steps like solvent extraction and crystallization. Careful control over reaction temperature and handling reagents ensures minimal by-products, keeping production costs in line. Filtration and drying round out the process, before rigorous in-process QA samples move the batch forward to packaging. Over the years, researchers continue tweaking this route to improve yield while lowering environmental impact by recycling solvents and optimizing waste management.
Levamisole’s imidazothiazole ring system is fairly robust, but it still allows for clever chemical tweaks. Through alkylation or acylation, researchers develop analogs in the search for related compounds with different therapeutic actions. The hydrochloride salt improves bioavailability, increasing the absorption rate when taken orally. Under strong acids or bases, the molecular integrity might suffer, which matters most for those looking to use it as a starting material for more complex pharmaceuticals. Some routes focus on producing enantiomerically pure forms, since the L-enantiomer brings better pharmacological activity versus the unwanted D-form, and this keeps medicinal chemists occupied in labs worldwide.
Depending on where you look, Levamisole Hydrochloride goes by numerous alternate names. In technical documents, it may be listed as 6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole hydrochloride. Sometimes, suppliers refer to it by brand names from past pharmaceutical campaigns, such as Ergamisol, Ketasol, or Decaris. Chemists recognize the CAS number 16595-80-5. In livestock circles, it appears on product rosters for dewormers and anthelmintics, sometimes blended with other actives to cover resistance issues. As an old hand in the pharma and vet fields, this compound carries different monikers but usually pops up in the same professional circles.
Handling Levamisole Hydrochloride means sticking to tough safety protocols. Pharmaceutical production plants require workers to wear gloves, goggles, protective gowns, and sometimes even respirators. Any contact with skin or eyes can cause irritation, and accidental ingestion in high doses creates nausea or vomiting. Since contamination risks exist, institutions train workers in spill cleanup, waste disposal, and inventory tracking. In the United States, OSHA and FDA rules guide workplace operations while European manufacturers follow EMA and REACH standards. Warehouses and pharmacies often rely on monitored temperature and humidity controls, and facilities keep spill kits on hand, just in case. It’s good sense: safe handling saves lives and keeps quality on target.
Levamisole Hydrochloride originally entered the fray as a broad-spectrum anthelmintic, fighting off gastrointestinal worms in cattle, sheep, pork, and goats. Over the years, clinicians also prescribed it off-label for human uses such as treatment of helminthic infections, and as an adjunct therapy for colon cancer and certain autoimmune conditions. The immunomodulator action gave hope in slowing disease progression for rheumatoid arthritis and nephrotic syndrome. Outside regulated uses, illicit drug markets sometimes cut street cocaine with Levamisole, raising red flags inside public health agencies. Front-line veterinarians depend on it for livestock health, keeping herds productive in settings where parasites challenge food security daily. Without these solutions, food systems and human health would stumble for want of basic protection.
Research teams worldwide keep returning to Levamisole Hydrochloride, not just for its direct clinical value, but as a tool to probe immune system regulation and cellular signaling. In recent years, studies tested its effects on inflammation, tumor markers, and neurological responses. Biomedical researchers often use it to induce neutrophil activity in animal models, learning more about immune cell migration, which informs new drug development in cancer, infectious disease, and immunology. On the chemical engineering front, ongoing work addresses greener synthesis methods, improved purification, and enantiomeric excess control. Research often finds itself running ahead of regulatory positions, but, as teams share findings on platforms like PubMed and in open-access journals, new uses and safety information keep expanding the knowledge base.
Toxicologists dug deep into Levamisole Hydrochloride after early reports of side effects ranging from nausea to life-threatening agranulocytosis. Animal studies set out to define LD50 values and catch subtle changes in blood cell counts, liver enzymes, and neurological symptoms. Regulatory agencies like the FDA and EFSA request full profiles for residue limits in animal-derived food products, fearing chronic exposure to consumers. Toxicity risks—especially with off-label and contaminated street drugs—pushed public health labs to refine detection and reporting tools. On balance, therapeutic doses offer good safety profiles, but poisoning cases have highlighted the need for robust prescription guidelines, clinical monitoring, and swift adverse event reporting. Having worked in clinics seeing parasitic infections first-hand, doctors and pharmacists know proper use keeps benefits far ahead of the risks.
Levamisole Hydrochloride has an uncertain, but no less important, future ahead. Resistance patterns in livestock parasites keep evolving, so rotational use and combined therapies will stay in play. Research circles look to enantiopure compounds and slow-release formulations, aiming to sharpen clinical value while cutting down side effects. In the oncology world, doctors sometimes revisit its immune-modulating power to boost cancer vaccine responses. Concerns over street drug contamination amplify the urgency to improve detection and public education. Policy makers and manufacturers face calls for continuous refinement in production, distribution, and stewardship, making sure this once-mainstay of the global therapeutics toolbox keeps delivering value safely, responsibly, and innovatively. As challenges crop up, history suggests Levamisole will adapt, guided by the lessons of prior decades and the needs of tomorrow’s clinicians, veterinarians, and patients.
Levamisole hydrochloride has a history that stretches from farm fields to hospitals. Decades ago, farm veterinarians relied on levamisole to treat livestock for worm infestations. The drug paralyzes and kills a range of intestinal parasites, which mattered for cattle, sheep, goats, and pigs whose health—and ultimately productivity—could fall quickly from heavy parasite burdens. I spent a summer working on a cattle ranch where keeping the animals healthy meant regular deworming. Levamisole injections were part of that toolkit, along with the usual fly treatments and vaccines.
Doctors discovered levamisole can help people with certain immune-related health conditions. By tweaking how white blood cells behave, the drug can boost immune response. In the past, it even joined chemotherapy treatment for colon cancer. Some doctors turned to it for diseases like nephrotic syndrome in kids, especially after more familiar drugs failed to work. After its use in colon cancer, researchers looked at it as an immune stimulant in several settings, hoping it could do for people what it did for livestock: fight off unwelcome organisms by improving defenses.
Patient safety shaped the new chapters of levamisole’s story. Cases started piling up: people who took levamisole developed agranulocytosis, a condition where white blood cells bottom out. People became extremely susceptible to infections. The FDA pulled its approval for levamisole’s use in people in the United States, though other countries still use it sparingly and with caution. If someone buys levamisole for their own health needs in the US, they will not find it at the local pharmacy. Instead, prescriptions and veterinary formulations are regulated with close oversight.
The name levamisole escaped the medical textbooks and showed up in street drug news. A large chunk of the cocaine supply found in North America has levamisole mixed in. The DEA and other agencies have tested seized batches over the years. In some cases, over 70% of tested cocaine has traces of this drug. Nobody knows for sure why, but some drug dealers claim levamisole improves the “high.” The real result isn’t so glamorous: users can get skin wounds, fevers, and severe drops in white blood cell counts without knowing what’s inside their drugs. Emergency rooms in big cities have seen people with necrotic skin and severe fungal infections, which doctors traced back to contaminated cocaine.
The story of levamisole highlights the importance of honest conversations about drug safety, whether dealing with livestock, people, or street drugs. Doctors need tools to help patients, but the risks with levamisole mean other options have taken its place for most purposes. For ranchers and pet owners, strict rules on dosing and withdrawal times matter. For doctors, regular blood monitoring is non-negotiable in the rare cases when levamisole gets prescribed.
People who use street drugs face a whole different set of risks. Harm reduction groups have started offering test strips and education to help users spot the signs of contamination. In my work with community health clinics, I’ve watched how important it is to meet people where they are, offer resources, and keep conversations non-judgmental if we want to help people stay alive and healthy.
I remember when my uncle was prescribed levamisole hydrochloride for his rheumatoid arthritis. The pharmacist gave us a quick sheet of warnings, but nobody sat down to talk about the real effects. Levamisole isn’t just another medication you pick up at the pharmacy—this drug has a long, complicated track record. Originally used for worm infestations and later as an immunomodulator, it’s serious business. People even began to realize it was cutting its way into illegal drugs like cocaine, with effects nobody bargained for.
Levamisole brings some familiar problems. Many report feeling nauseous or vomiting soon after starting it, and stomach pain isn’t just a rare complaint. Diarrhea and even mouth ulcers—sometimes big enough to keep people from eating—show up often. Skin rashes or itching can drive people nuts, too. One thing I’ve seen personally: fatigue hits people hard. They talk about feeling a bone-deep tiredness they can’t shake, even with proper rest.
What gets scary fast is something called agranulocytosis. This isn’t just a tongue-twister; it means your body’s white blood cell count drops dangerously low. When that happens, you’re wide open to infections—sometimes life-threatening ones. There have been cases where folks needed hospital care after their immune system got clobbered. Some studies from Johns Hopkins and other major hospitals show up to 10% of patients treated long-term ended up with this serious drop in white cells. With all the immune risks already floating around, this isn’t something any healthcare provider can afford to ignore.
Levamisole seems to tap into the nervous system in odd and troubling ways. Some users have reported confusion, mood swings, or even hallucinations. I’ve read documentation of seizures, in rare cases, which raises alarm bells for people with epilepsy or neurological conditions. In medicine, drugs like this stir up more than just the physical, and doctors at the Mayo Clinic have flagged these neuropsychiatric reactions as real hazards.
No one benefits from downplaying risk. Open conversations with healthcare professionals matter a lot. Many don’t realize simple blood tests can pick up on serious immune problems long before symptoms explode. Physicians should ask questions at every visit, looking for the subtle signs: Did you get a sore throat that won't quit? Are you bruising for no reason? A little curiosity can save a life.
By sticking to safe prescribing and monitoring, doctors keep tabs on things before they get out of hand. Patients have a part to play, too. Reporting strange symptoms early means acting before trouble snowballs. If levamisole hydrochloride is the best tool in the box, risks don’t have to turn into harm—provided everyone stays watchful and honest about the cracks that can appear along the way.
Doctors prescribe Levamisole Hydrochloride for a good reason—it has stood the test of time, especially in fighting parasitic infections and sometimes in treating autoimmune diseases. Over the years, I’ve seen patients anxious to get the details right, unsure whether to swallow, mix, or inject their medicine. Safety hangs on the exact way a medication is used. For Levamisole, the route matters; oral tablets form the backbone of its delivery, but in rare cases, injections play a role under a doctor’s direction.
I’ve listened to many parents ask about dosage, especially when dealing with tough worms in children. Swallowing a tablet feels direct. The pill should be taken with water, not on an empty stomach. It helps calm the belly and cuts down the odds of feeling sick. Skipping meals with medication might seem trivial, but small steps—like eating beforehand—spare families an extra trip to the doctor for side effects. Dosing follows the numbers set out by health regulators, usually measured out based on weight, which can mean one dose and done, or a short series when dealing with stubborn cases.
Sometimes, oral treatment isn’t an option—think severe illness, difficulty swallowing, or rapid intervention. Hospitals turn to intravenous or intramuscular injections in emergencies. Nurses double-check everything, sterile syringes at the ready. These scenarios stick in my mind because errors have consequences. Getting dosages right, cotrolling infection risk—these steps are drilled into any good nurse or doctor. This method stays with trained professionals, not family kitchens.
Taking medicine lightly or guessing at home can land people in trouble. Levamisole doses rely on weight. Underdosing leaves infections behind; overdosing risks nausea, headaches, or worse. There’s nothing fancy here—grab a reliable kitchen scale if needed and leave nothing to chance if a prescription calls for precision. Pharmacists become the unsung experts; they answer the late-night calls, break down the numbers, and remind patients stick to what the doctor ordered.
Sometimes people mash pills or break tablets to stretch a supply or help a child swallow. This move can backfire. The powder doesn’t always mix evenly into juice or water, leaving doses unreliable or unpalatable. Liquid formulations exist but need to come from a registered pharmacist to avoid errors. Some parents ask about crushing the tablet and sneaking it into food; while sometimes approved, a chat with the prescriber is always smarter, as certain foods can change how medicine works.
There’s been a rise in people turning to the internet for medicine. Levamisole isn't immune from counterfeit risks. Buying from trusted pharmacies protects against fake or contaminated sources, which could make a tough situation worse. Calling your local pharmacist or licensed provider remains one of the best ways to safeguard your health.
Handling Levamisole Hydrochloride goes beyond just taking a pill. Understanding directions from licensed professionals—doctors and pharmacists—protects well-being and ensures the medicine works as intended. Side effects, misdosing, and counterfeit products all matter. Strong communication with healthcare teams and old-fashioned common sense lay the right foundation for safe and effective treatment.
Levamisole hydrochloride started as a medicine for animals, fighting off parasitic infections. Over time, doctors figured out it could help with some human health problems, including certain autoimmune diseases and as a supportive medicine in some cancer treatments. It’s important to recognize that, like all drugs, this one brings benefits to the table, but comes with a list of risks that every patient and healthcare provider should know about before starting therapy.
Levamisole hydrochloride is not the right choice for everyone. Some medical situations actually make this drug a threat rather than a solution. People dealing with a history of certain blood problems, like agranulocytosis or other types of blood cell disorders, should not take this medication. Levamisole can severely decrease white blood cell counts, making it dangerous for those with weakened immune systems.
Those who have shown allergic reactions to levamisole or any of its components in the past must avoid it. No need to risk a severe allergy or anaphylaxis when safer options exist. Allergic responses can escalate fast, and a single wrong dose can mean an ER visit.
Sound liver and kidney function play a huge role in how the body handles medication. Patients with significant liver damage, cirrhosis, or other chronic liver diseases hold a greater risk for unpredictable side effects. Their bodies can’t filter the medicine as efficiently, leading to higher concentrations in the blood and more toxicity. Chronic kidney problems can produce similar trouble, and few things are more frustrating than treating one problem only to spark another.
Doctors exercise extra caution with pregnant women and nursing mothers. Levamisole’s effects on human pregnancies aren’t fully understood but animal studies have shown negative outcomes. Most women hear this and ask for something else. The risk just outweighs the possible benefit. The same goes for breastfeeding mothers—medicine that passes into breastmilk can directly reach the baby and the safety profile just isn’t there.
Children aren’t just small adults. Their developing organs process medicines differently and their immune systems are much more sensitive. Levamisole sometimes finds its way into pediatric care, particularly for certain kidney diseases, but only under careful medical supervision and after other treatments have failed.
Levamisole can interact with other drugs that suppress the immune system or lower blood counts. Anyone already taking medicines like methotrexate, chemotherapy drugs, or regular steroids faces a higher likelihood of dangerous side effects, including severe infections. It’s not about stacking up pill bottles—patients should always tell their healthcare providers about every supplement, herb, or medicine they use.
What matters most is having open, honest conversations between patients and healthcare providers. People familiar with the task of managing chronic illness know that understanding the risks connected to each medication keeps surprises to a minimum. Regular blood work helps catch complications early, but recognizing symptoms—like fevers, sore throats, or unexplained bruising—does even more.
Staying informed, asking questions, and sharing changes in health with a doctor forms the best defense against drug-related problems. Medicine asks for teamwork, especially with something as complex as levamisole hydrochloride. The goal remains the same—offer the benefits without stepping into harm’s way.
Levamisole Hydrochloride earned its place in veterinary clinics as a dewormer. Livestock producers saw quick results in treating roundworm infections in cattle, sheep, pigs, and goats. Between pasture rotations and crowded pens, parasites thrive, leading to sick animals and lost income. Levamisole stepped in with a promise to turn things around, and for a long time, producers across continents depended on it because it often worked when nothing else did.
Looking back at my neighbors who raised cattle, I remember the worry they felt during heavy worm seasons. Levamisole became a regular part of their toolkit. Every dose brought some relief because healthy cows meant more milk for the market and less stress about losing calves to parasite overload. The drug did its job, but farmers paid attention to safety; overdosing spelled disaster, sometimes even death for animals.
As research moved forward during the twentieth century, scientists wondered whether levamisole could offer hope in human medicine. Doctors in several countries tried using it as an anti-parasitic for gastrointestinal worms. Its popularity picked up when no affordable alternatives existed, especially in places where infections ruled out daily comfort.
Years ago, the prospect of using veterinary drugs for people did not raise as many eyebrows. Some hospitals gave levamisole to patients living with poor sanitation, making headway against life-disrupting worm infections. Beyond that, trials began exploring levamisole as an immune modulator, especially for people with autoimmune diseases and cancer. For a short window, kids with low white blood cell counts due to leukemia included levamisole as part of their regimens.
No drug travels a smooth road. Over time, people noticed some nasty side effects. Cases of agranulocytosis—where the body’s white blood cells fall dangerously low—sometimes landed unsuspecting users in the hospital. A healthy immune system became a gamble. This risk led to rapid restrictions, especially in North America and Europe.
Levamisole’s challenges did not end there. Some illicit drug manufacturers began adding it to street cocaine, hoping to "cut" the product for greater profits. This scheme backfired, causing severe tissue damage and immune complications. Emergency rooms started seeing puzzling cases of skin dying off, baffling some doctors until they traced it back to levamisole-tainted drugs.
Levamisole can still matter for animals, but careful dosing and regulation have become the norm. Governments around the world monitor its use and limit exposure to keep both livestock and food consumers safe.
Doctors rarely prescribe levamisole for people in the modern era, searching instead for safer options. Where worms still haunt families, newer drugs are preferred. The skill lies in weighing the risk against the need, and having honest conversations about what truly keeps people safe.
Pharmacists and veterinarians keep learning about drugs like levamisole, pushing for clear rules to protect everyone—animals and people alike. The story of levamisole reminds us that every benefit has a tradeoff. No drug stays static. Investments in research carve out new solutions, because sick animals become sick communities, and mismanaged risks echo through every meal we share.
Science does not stand still. Neither do problems like parasites and immune diseases. Building safer, effective treatments and keeping a sharp eye on side effects—this is the way forward.
| Names | |
| Preferred IUPAC name | (6S)-6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole hydrochloride |
| Other names |
Ergamisol Tetramisole hydrochloride Levamisole HCl Ketrax LMS |
| Pronunciation | /lɪˈvæmɪˌsoʊl haɪˌdrɒklaɪd/ |
| Preferred IUPAC name | (6S)-6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole hydrochloride |
| Other names |
Tetramisole hydrochloride Ergamisol Levamisol HCl Levamisole HCl Levamizol Ketrax Decaris-HCL |
| Pronunciation | /lɪˈvæmɪsoʊl haɪˌdrɒklaɪd/ |
| Identifiers | |
| CAS Number | 16595-80-5 |
| 3D model (JSmol) | `3D model (JSmol)` string for **Levamisole Hydrochloride**: ``` data smiles "CN1C=NC2=C1N=CN2[C@@H]3CCCN3.Cl" ``` |
| Beilstein Reference | 1365492 |
| ChEBI | CHEBI:6432 |
| ChEMBL | CHEMBL1643 |
| ChemSpider | 110409 |
| DrugBank | DB00848 |
| ECHA InfoCard | 100.043.313 |
| EC Number | 3.1.3.13 |
| Gmelin Reference | 1262453 |
| KEGG | D08110 |
| MeSH | D008695 |
| PubChem CID | 71397 |
| RTECS number | UMG22074M0 |
| UNII | NY9RMC07L1 |
| UN number | UN3248 |
| CAS Number | 16595-80-5 |
| Beilstein Reference | 1748457 |
| ChEBI | CHEBI:63698 |
| ChEMBL | CHEMBL1506 |
| ChemSpider | 10974 |
| DrugBank | DB00848 |
| ECHA InfoCard | 03fdd3b6-fcbc-486b-9b36-a9031b0f7279 |
| EC Number | 3.1.3.7 |
| Gmelin Reference | 85766 |
| KEGG | D08109 |
| MeSH | D008695 |
| PubChem CID | 71395 |
| RTECS number | QY1225000 |
| UNII | 69M228532I |
| UN number | UN3249 |
| Properties | |
| Chemical formula | C11H13N2S·HCl |
| Molar mass | 204.72 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.175 g/cm³ |
| Solubility in water | Soluble in water |
| log P | 0.96 |
| Acidity (pKa) | 7.0 |
| Basicity (pKb) | 7.07 |
| Magnetic susceptibility (χ) | -62.5×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.764 |
| Dipole moment | 4.03 D |
| Chemical formula | C11H13N2S·HCl |
| Molar mass | 204.72 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.175 g/cm3 |
| Solubility in water | Freely soluble in water |
| log P | 1.61 |
| Acidity (pKa) | 7.0 |
| Basicity (pKb) | 11.0 |
| Magnetic susceptibility (χ) | -65.0e-6 cm³/mol |
| Refractive index (nD) | 1.766 |
| Viscosity | Viscous liquid |
| Dipole moment | 2.06 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 385.65 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -183.6 kJ/mol |
| Std molar entropy (S⦵298) | 247.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -261.4 kJ/mol |
| Pharmacology | |
| ATC code | P02CE01 |
| ATC code | P02CE01 |
| Hazards | |
| Main hazards | May cause sensitization by skin contact and by inhalation. Harmful if swallowed, inhaled, or absorbed through the skin. Causes irritation to skin, eyes, and respiratory tract. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07 |
| Signal word | **Warning** |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | Keep container tightly closed. Store in a cool, dry place. Avoid breathing dust. Wash thoroughly after handling. Use with adequate ventilation. Avoid contact with eyes, skin, and clothing. |
| NFPA 704 (fire diamond) | NFPA 704: 2-3-0 |
| Flash point | > 190.2 °C |
| Autoignition temperature | 500°C |
| Lethal dose or concentration | LD₅₀ (oral, rat): 180 mg/kg |
| LD50 (median dose) | LD50 (median dose): 180 mg/kg (oral, rat) |
| NIOSH | WQ9300000 |
| PEL (Permissible) | PEL: 5 mg/m³ |
| REL (Recommended) | 7.5 mg/kg |
| IDLH (Immediate danger) | Not established |
| Main hazards | Harmful if swallowed. Causes skin and eye irritation. May cause allergic skin reaction. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS05,GHS07 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | P264, P270, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | 2-2-0 Health:2 Flammability:2 Instability:0 |
| Lethal dose or concentration | LD50 oral rat 180 mg/kg |
| LD50 (median dose) | LD50 (median dose): Mouse oral 180 mg/kg |
| NIOSH | NLM8591000 |
| PEL (Permissible) | 5 mg/m³ |
| REL (Recommended) | 7.5 mg/kg |
| IDLH (Immediate danger) | Unknown |
| Related compounds | |
| Related compounds |
Tetramisole Levamisole Piperazine Imidazothiazole Thiabendazole Pyrantel |
| Related compounds |
Tetramisole Levamisole Morantel Pyrantel Methyridine |